ARCHIVES

Second-Generation CML Drugs Show Promise For Frontline

This article is from The Cancer Letter archive.

Vol. 31 No. 12 | December 26, 2008

Download PDF Visit The Full Archive

Related Articles

NCI Makes First NRS Award – 13 Institution Grants; 150 Individuals Pending: Lepovetsky Training Chief

April 4, 1975

Support Contracts For Management Info, ODQ Updating Ok’d

October 12, 1990

Enzastaurin Shows Activity In Recurrent High-Grade Glioma

June 24, 2005

NCI Proposes Consolidation of Nine Cooperative Groups to Four

December 17, 2010

Rosenberg Team May Have Cloned Melanoma Gene

May 31, 1991

Professional Societies: ONS To Study Trends In Health Economics Affecting Nursing

October 4, 1996